Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T16:17:39.011Z.
Calculation as of: 2026-10-06T16:17:39.011Z.
Quote observation: 2026-10-06T16:15:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
Latigo Biotherapeutics Inc.
Market Cap
$1.01B
EV/Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$998.12M
EV/Assets Ratio
1.99x
TTM Avg
1.37x
3Y Avg
1.36x
5Y Avg
1.36x
Market Cap
$1.02B
EV/Assets Ratio
1.06x
TTM Avg
1.08x
3Y Avg
1.08x
5Y Avg
1.08x
Market Cap
$993.23M
EV/Assets Ratio
1.76x
TTM Avg
2.57x
3Y Avg
5.48x
5Y Avg
5.04x
Market Cap
$991.26M
EV/Assets Ratio
2.42x
TTM Avg
3.59x
3Y Avg
2.22x
5Y Avg
1.85x
Market Cap
$984.16M
EV/Assets Ratio
0.96x
TTM Avg
1.00x
3Y Avg
1.03x
5Y Avg
1.35x
Market Cap
$987.92M
EV/Assets Ratio
1.64x
TTM Avg
2.33x
3Y Avg
2.33x
5Y Avg
2.33x
Market Cap
$1.03B
EV/Assets Ratio
0.80x
TTM Avg
0.79x
3Y Avg
0.88x
5Y Avg
1.15x
Market Cap
$1.04B
EV/Assets Ratio
1.80x
TTM Avg
1.48x
3Y Avg
1.28x
5Y Avg
1.23x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Latigo Biotherapeutics Inc. (LTGO) | $1.01B | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $998.12M | 1.99x | 1.37x | 1.36x | 1.36x |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.06x | 1.08x | 1.08x | 1.08x |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $993.23M | 1.76x | 2.57x | 5.48x | 5.04x |
| MeiraGTx Holdings plc (MGTX)vs › | $991.26M | 2.42x | 3.59x | 2.22x | 1.85x |
| Pacira BioSciences, Inc. (PCRX)vs › | $984.16M | 0.96x | 1.00x | 1.03x | 1.35x |
| Aktis Oncology, Inc. (AKTS)vs › | $987.92M | 1.64x | 2.33x | 2.33x | 2.33x |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 0.80x | 0.79x | 0.88x | 1.15x |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | 1.80x | 1.48x | 1.28x | 1.23x |
| Immatics N.V. (IMTX)vs › | $1.04B | 1.43x | 1.49x | 1.27x | 1.39x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
